2025-05-01 2026-04-30 false No description of principal activity Acting Office - Tax and Accounts 1.0 10733880 bus:FullAccounts 2025-05-01 2026-04-30 10733880 bus:Micro-entities 2025-05-01 2026-04-30 10733880 bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 10733880 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 10733880 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 10733880 2025-05-01 2026-04-30 10733880 2026-04-30 10733880 bus:RegisteredOffice 2025-05-01 2026-04-30 10733880 core:WithinOneYear 2026-04-30 10733880 core:AfterOneYear 2026-04-30 10733880 2024-05-01 10733880 bus:Director1 2025-05-01 2026-04-30 10733880 bus:Director1 2026-04-30 10733880 bus:Director1 2024-05-01 2025-04-30 10733880 bus:CompanySecretary1 2025-05-01 2026-04-30 10733880 bus:LeadAgentIfApplicable 2025-05-01 2026-04-30 10733880 2024-05-01 2025-04-30 10733880 2025-04-30 10733880 core:WithinOneYear 2025-04-30 10733880 core:AfterOneYear 2025-04-30 10733880 bus:EntityAccountantsOrAuditors 2024-05-01 2025-04-30 10733880 core:Goodwill 2025-05-01 2026-04-30 10733880 core:Goodwill 2026-04-30 10733880 core:Goodwill 2025-04-30 10733880 core:CostValuation core:Non-currentFinancialInstruments 2026-04-30 10733880 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 10733880 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 10733880 core:Non-currentFinancialInstruments 2026-04-30 10733880 core:Non-currentFinancialInstruments 2025-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10733880
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 30 April 2026

for

VECTIS CLINICAL SOLUTIONS LIMITED

 
 
 
£
2026
£
   
£
2025
£
Fixed assets (1) (1)
Current assets 16,521  20,243 
Net current assets/(liabilities) 16,521  20,243 
Total assets less current liabilities 16,520  20,242 
Accruals and deferred income (73) (64)
Net assets/(liabilities) 16,447  20,178 
 
Capital and reserves 16,447  20,178 
 
  1. For the year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


---------------------------------------------
Andrew Gordon Bruce Graham
Director

Date approved: 31 May 2026
1
Statutory Information
Vectis Clinical Solutions Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 10733880, registration address Apollo House, Hallam Way, Whitehills Business Park, Blackpool, FY4 5FS, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2025: 1).
3.

Director Advances Credits Note

At 30 April 2026 the director owed £429.99 to VECTIS CLINICAL SOLUTIONS LIMITED
2